Nitish Kumar

Minimally invasive surgical therapies (MIST) for benign prostatic hyperplasia: Initial single-center experience

Background: Minimally invasive surgical therapies (MIST) have emerged as effective alternatives to transurethral resection of the prostate for the management of benign prostatic hyperplasia (BPH), offering symptomatic relief with reduced morbidity and preservation of sexual funct...